O

Optus Pharmaceutical Co Ltd
KOSDAQ:131030

Watchlist Manager
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Watchlist
Price: 6 930 KRW -1.28%
Market Cap: 122.3B KRW

Wall Street
Price Targets

Price Targets Summary
Optus Pharmaceutical Co Ltd

There are no price targets for Optus Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Optus Pharmaceutical Co Ltd Competitors:
Price Targets
LNTH
Lantheus Holdings Inc
26% Upside
OMED
Jayamas Medica Industri TBK PT
6% Upside
UFPT
UFP Technologies Inc
25% Upside
2276
Shanghai Conant Optical Co Ltd
5% Upside
PNV
Polynovo Ltd
59% Upside
6491
Pegavision Corp
27% Upside
AMS
Advanced Medical Solutions Group PLC
28% Upside
MMSI
Merit Medical Systems Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Optus Pharmaceutical Co Ltd

The compound annual growth rate of Optus Pharmaceutical Co Ltd's revenue for the next 7 years is 30%.

N/A
Past Growth
30%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Optus Pharmaceutical Co Ltd

The compound annual growth rate of Optus Pharmaceutical Co Ltd's operating income for the next 7 years is 50%.

N/A
Past Growth
50%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Optus Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Optus Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 7 years is 7%.

24%
Past Growth
7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Optus Pharmaceutical Co Ltd's stock price target?
Not Available

Optus Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Optus Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
30%

The compound annual growth rate of Optus Pharmaceutical Co Ltd's revenue for the next 7 years is 30%.

What is Optus Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
50%

The compound annual growth rate of Optus Pharmaceutical Co Ltd's operating income for the next 7 years is 50%.

What is Optus Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Optus Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 7 years is 7%.

Back to Top